News|Articles|June 25, 2018

In the Lab eNewsletter

  • Pharmaceutical Technology\'s In the Lab eNewsletter-07-03-2018
  • Volume 13
  • Issue 7

Waters’ New UPLC Platform Meets Evolving Chromatography Needs

The company’s next-generation ultraperformance liquid chromatography platform is designed to meet the evolving laboratory requirements for chromatographic performance.

Waters’ Acquity ultraperformance liquid chromatography (UPLC) PLUS Series-three new Acquity UPLC Systems-builds off of the success of the company’s Acquity UPLC separations platform. The company designed the new Acquity systems-UPLC H-Class PLUS, H-Class PLUS Bio, and IClass PLUS Systems-based, in part, on customer feedback.

The new systems offer enhanced flexibility, performance, and ease-of-use. They have various applications, including peptide mapping and routine product-release testing and can be used to meet academic, pharmaceutical, food, and chemical-industry laboratory research, development, and quality-control objectives.

The Acquity UPLC PLUS Systems debuted at the Analytica Conference, on April 10–13, 2018 in Munich, Germany.

“When introduced in 2004, the ACQUITY UPLC System transformed laboratory science by bringing dramatic business and scientific benefits to the analytical process. And it was met with overwhelming customer acclaim considering it had been 30 years since liquid chromatography saw such dramatic performance improvements,” said Eric Grumbach, director of product marketing, Chromatography Systems, Waters, in a company press release. “At Waters, innovation is about more than just performance. It’s about listening to the customer and continuously pushing our LC technology forward to find faster, simpler, and better ways to support the work that they do.”

Source: Waters


Related to this article

Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation. | Image Credit: ©HockleyMedia24/peopleimages.com -stock.adobe.com
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
PharmTech Weekly Roundup—October 2, 2026
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.